Clinical trials have supported this, with one study finding that individuals taking semaglutide at a dose of 2.4mg lost an average of 14.9% of their body weight after 68 weeks of treatment, whilst also following a diet and exercise plan
Clinical Evidence: Study Outcomes and Realistic Expectations Clinical research on both compounds remains limited compared to pharmaceutical-grade biologics
The same applied for PBMC mitochondrial functionality and metabolic activity as assessed by ex vivo approaches, whereas non-mitochondrial respiration rate was significantly affected by L-carnitine supplementation over time
However, it is equally important to explore other potential causes, such as poorly controlled blood glucose levels, thyroid dysfunction, vitamin deficiencies, or sleep disorders, all of which can affect mood
Retatrutide posted 24% body weight loss in Phase 2 by targeting three receptors instead of one
Khan M, Gross J, Haupt H, et al